Elton John welcomes expansion of opt-out testing for HIV to 46 Accident & Emergency sites across England and calls on all political leaders to do more to end AIDS in a speech at Speaker’s House

Elton John was honored at a reception hosted by the All Party Parliamentary Group on HIV/AIDS at the Speaker’s House today in recognition of his enduring commitment to ending the AIDS epidemic, both personally and through the work of the Elton John AIDS Foundation.

Synaffix joins forces with Sotio on $740M ADC licensing deal, plans expansion after Lonza acquisition

Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to use the Dutch

October 17, 2023

Pharmalittle: We’re reading about a CVS deal with Illinois, a Pfizer hemophilia therapy, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

July 24, 2024

Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday. The remarks

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.